Dear friends of the DRFZ, An eventful year is almost over. We wish all colleagues and friends of the DRFZ a peaceful and relaxing holiday season. We look forward to an exciting new year together in 2025!

Bimodal single-cell RNA-seq data reveals four distinct modalities, uncovering genes tied to splicing, transcription & degradation rates. DRFZ Zuse Institute Berlin Mashreghi_Lab #vikram_sunkara academic.oup.com/nargab/article…

Probiotics are good for us, right? International experts took on the literature in Nature Reviews Gastroenterology & Hepatology and found more research is needed to determine what exactly makes for a healthy #microbiome. We talked to #mdcBerlin's Sofia Forslund, who was on the panel: mdc-berlin.de/news/news/real…

🚨The moment you've been waiting for has arrived! #EULAR2025 abstract submissions are now OPEN! 🗓️ Submission Deadline: 15 January 2025. Submit now 👉 pulse.ly/sz9d45yl3t #EULAR #Research #Barcelona #CallForAbstracts

Nominations are open for the IUIS Excellence in Immunology (EXCELL) Award! This special award recognizes women and non-binary immunologists for their outstanding research accomplishments. This $40,000 USD prize will be awarded at #IUIS2025! Learn more: loom.ly/QM7AWB4

🚨 Reminder: Abstract submissions for IUIS 2025 are due January 31st! 🌍 Showcase your discoveries in Vienna, Austria, this summer. Don’t wait—submit now to join #IUIS2025! ✨ iuis2025.org

⏳ Last chance! The case report submission deadline is TOMORROW! 🌟Don’t miss the opportunity to contribute to the future of rheumatology. 📅 Deadline: 15 January 2025 Submit now👉 bit.ly/3YaFEZm Watch here👉 bit.ly/4eQgV20 #EULAR #Rheumatology #CaseReports

🚨 EXTENDED DEADLINE: Good news, abstracts are now due on February 11th!!! 🌍 Showcase your discoveries in Vienna, Austria this summer. Don’t wait—submit now to join #IUIS2025! ✨ iuis2025.org!

Good morning from Jena. We just opened the 8th German Mass Cytometry User Forum with the Getting Started tutorial. We are looking forward to 2 days full of Mass Cytometry!

Diana Dudziak & Sabine Baumgart from Jena University Hospital and Axel Schulz, DRFZ, warmly welcomed the participants of the 8th German Mass Cytometry User Forum in Jena. We are exited for inspiring presentations, engaging discussions and valuable exchanges throughout the event.

Many thanks to all our industry partners for supporting our meeting. During the Techno Bites, they impressed us with their latest innovations for #masscytometry.

After a successful day filled with exciting #masscytometry data and insightful discussions, we would like to thank all the speakers for their contributions.

The two days of our meeting have flown by. We had the opportunity to listen to inspiring presentations, sharing experiences, gain valuable insights into the latest techniques and applications of #masscytometry, engage in insightful discussions, and establish new collaborations.

Congratulations to Yola Gerking, University of Bergen, Norway, for the best poster presentation and Matthieu van Tilbeurgh, CEA, France, for the best short talk of the German Mass Cytometry User Forum.

Chiara Romagnani, Liaison Group Leader at DRFZ, is a new member of the Leopoldina. This membership is considered one of the highest scientific honors and recognitions in Germany and beyond. Congratulations! bit.ly/42XMdkQ

DRFZ with a new look: modern logo and new website The DRFZ now has a fresh new look! With a new logo and a revised colour scheme, the DRFZ reflects its future-oriented approach to rheumatological research: drfz.de

Prof. Dr. Thomas Krieg is the new President of the Board of Trustees of the DRFZ, succeeding Prof. Dr. Elisabeth Märker-Hermann. Dr. med. Julia Rautenstrauch is elected Vice President of the Board of Trustees. drfz.de/en/neuigkeiten…

Exciting publication in Nature by DRFZ researchers. Congratulations! Original publication: bit.ly/3Fn63Mt DRFZ News: bit.ly/4kJ1AUq

Just published nature How does #SARSCoV2 lead to the multi-system inflammatory syndrome in children, a rare, potentially fatal condition? High levels of TGFβ interfere with the child's response to control Epstein Barr virus, leading to its reactivation and severe inflammation

The DRFZ is leaving X. You could find us on LinkedIn, Bluesky and Facebook. We are looking forward to stay in contact with you there.